Laboratory & Sample Management

How Lab Audits & Accreditation (CLIA/CAP/ISO) Supports Regulatory Submissions and Inspection Readiness

Posted on By digi

How Lab Audits & Accreditation (CLIA/CAP/ISO) Supports Regulatory Submissions and Inspection Readiness How Lab Audits & Accreditation (CLIA/CAP/ISO) Supports Regulatory Submissions and Inspection Readiness In the ever-evolving landscape of clinical trials, laboratory audits and accreditations are paramount for ensuring regulatory compliance and optimizing the assurance of quality in clinical trial data. This comprehensive guide explores…

Read More “How Lab Audits & Accreditation (CLIA/CAP/ISO) Supports Regulatory Submissions and Inspection Readiness” »

Lab Audits & Accreditation (CLIA/CAP/ISO)

Risk Management and Contingency Planning for Lab Audits & Accreditation (CLIA/CAP/ISO) Failures

Posted on By digi

Risk Management and Contingency Planning for Lab Audits & Accreditation (CLIA/CAP/ISO) Failures Risk Management and Contingency Planning for Lab Audits & Accreditation (CLIA/CAP/ISO) Failures In the complex realm of clinical research, ensuring that laboratory operations meet accreditation standards is paramount to the success of clinical trials and patient safety. Audits by regulatory authorities such as…

Read More “Risk Management and Contingency Planning for Lab Audits & Accreditation (CLIA/CAP/ISO) Failures” »

Lab Audits & Accreditation (CLIA/CAP/ISO)

Training Site and Lab Staff to Execute Lab Audits & Accreditation (CLIA/CAP/ISO) Reliably

Posted on By digi

Training Site and Lab Staff to Execute Lab Audits & Accreditation (CLIA/CAP/ISO) Reliably Training Site and Lab Staff to Execute Lab Audits & Accreditation (CLIA/CAP/ISO) Reliably In the realm of clinical trials, especially those focused on schizophrenia clinical trials near me, the integrity of laboratory practices is paramount to achieving reliable results and maintaining compliance…

Read More “Training Site and Lab Staff to Execute Lab Audits & Accreditation (CLIA/CAP/ISO) Reliably” »

Lab Audits & Accreditation (CLIA/CAP/ISO)

Vendor and Central Lab Oversight Models to Strengthen Lab Audits & Accreditation (CLIA/CAP/ISO)

Posted on By digi

Vendor and Central Lab Oversight Models to Strengthen Lab Audits & Accreditation (CLIA/CAP/ISO) Vendor and Central Lab Oversight Models to Strengthen Lab Audits & Accreditation (CLIA/CAP/ISO) In the landscape of clinical trials, the integrity of laboratory results plays a crucial role in achieving regulatory compliance and ensuring patient safety. With the rise of complex multi-site…

Read More “Vendor and Central Lab Oversight Models to Strengthen Lab Audits & Accreditation (CLIA/CAP/ISO)” »

Lab Audits & Accreditation (CLIA/CAP/ISO)

Aligning Deviations, Re-draws & Re-tests With Protocol, PK/PD and Biomarker Strategies

Posted on By digi

Aligning Deviations, Re-draws & Re-tests With Protocol, PK/PD and Biomarker Strategies Aligning Deviations, Re-draws & Re-tests With Protocol, PK/PD and Biomarker Strategies Introduction to Clinical Research Management In the realm of clinical research, the precision of data collection, analysis, and compliance is paramount. This includes a robust understanding of protocols and the management of deviations,…

Read More “Aligning Deviations, Re-draws & Re-tests With Protocol, PK/PD and Biomarker Strategies” »

Deviations, Re-draws & Re-tests

Common Pitfalls in Deviations, Re-draws & Re-tests—and How to Avoid Data and Safety Risks

Posted on By digi

Common Pitfalls in Deviations, Re-draws & Re-tests—and How to Avoid Data and Safety Risks Common Pitfalls in Deviations, Re-draws & Re-tests—and How to Avoid Data and Safety Risks In clinical research, maintaining the integrity of data is of utmost importance. Deviations, re-draws, and re-tests can introduce significant risks to both the data quality and the…

Read More “Common Pitfalls in Deviations, Re-draws & Re-tests—and How to Avoid Data and Safety Risks” »

Deviations, Re-draws & Re-tests

Deviations, Re-draws & Re-tests in Practice: Step-by-Step Guide for Sponsors and CROs

Posted on By digi

Deviations, Re-draws & Re-tests in Practice: Step-by-Step Guide for Sponsors and CROs Deviations, Re-draws & Re-tests in Practice: Step-by-Step Guide for Sponsors and CROs Introduction to Deviations in Clinical Trials In the realm of clinical research informatics, managing deviations, re-draws, and re-tests is a critical component to ensure the integrity of trial data and adherence…

Read More “Deviations, Re-draws & Re-tests in Practice: Step-by-Step Guide for Sponsors and CROs” »

Deviations, Re-draws & Re-tests

How to Design Deviations, Re-draws & Re-tests That Meets FDA, EMA and CLIA/CAP Expectations

Posted on By digi

How to Design Deviations, Re-draws & Re-tests That Meet FDA, EMA and CLIA/CAP Expectations In the realm of clinical trials, particularly prostate cancer clinical trials, the integrity of sample management is of paramount importance. Deviations, re-draws, and re-tests are not just operational nuances; they are critical components that must be meticulously managed to comply with…

Read More “How to Design Deviations, Re-draws & Re-tests That Meets FDA, EMA and CLIA/CAP Expectations” »

Deviations, Re-draws & Re-tests

Deviations, Re-draws & Re-tests: Operating Blueprint for Global GCP-Compliant Studies

Posted on By digi

Deviations, Re-draws & Re-tests: Operating Blueprint for Global GCP-Compliant Studies Deviations, Re-draws & Re-tests: Operating Blueprint for Global GCP-Compliant Studies Introduction to Deviations, Re-draws, and Re-tests in Clinical Trials The execution of clinical trials governed by Good Clinical Practice (GCP) requires meticulous attention to detail, especially concerning deviations, re-draws, and re-tests. These components are critical…

Read More “Deviations, Re-draws & Re-tests: Operating Blueprint for Global GCP-Compliant Studies” »

Deviations, Re-draws & Re-tests

Integrating Deviations, Re-draws & Re-tests With Laboratory Compliance and Accreditation

Posted on By digi

Integrating Deviations, Re-draws & Re-tests With Laboratory Compliance and Accreditation Integrating Deviations, Re-draws & Re-tests With Laboratory Compliance and Accreditation The global landscape of clinical trials is intricate and multifaceted, particularly concerning the proper management of non-compliance issues such as deviations, re-draws, and re-tests. Effective oversight of these issues is paramount to maintaining the integrity…

Read More “Integrating Deviations, Re-draws & Re-tests With Laboratory Compliance and Accreditation” »

Deviations, Re-draws & Re-tests